

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.80617849 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21474202 |
| 3 | germinal center formation (GO:0002467) | 3.10787096 |
| 4 | * phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.05800524 |
| 5 | cellular response to ethanol (GO:0071361) | 3.00580035 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 3.00502525 |
| 7 | interkinetic nuclear migration (GO:0022027) | 2.99107706 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98713027 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 2.96816089 |
| 10 | B cell receptor signaling pathway (GO:0050853) | 2.96300269 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94982016 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.93645175 |
| 13 | histone H3-K36 demethylation (GO:0070544) | 2.92940657 |
| 14 | Rap protein signal transduction (GO:0032486) | 2.91030100 |
| 15 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.90705460 |
| 16 | cellular extravasation (GO:0045123) | 2.88839279 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88617923 |
| 18 | dendrite morphogenesis (GO:0048813) | 2.74944829 |
| 19 | embryonic process involved in female pregnancy (GO:0060136) | 2.73367834 |
| 20 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.72475159 |
| 21 | positive regulation of muscle hypertrophy (GO:0014742) | 2.72475159 |
| 22 | hypotonic response (GO:0006971) | 2.69172057 |
| 23 | definitive hemopoiesis (GO:0060216) | 2.68437798 |
| 24 | histone lysine demethylation (GO:0070076) | 2.67747867 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64448721 |
| 26 | nerve growth factor signaling pathway (GO:0038180) | 2.63597667 |
| 27 | regulation of histone H3-K27 methylation (GO:0061085) | 2.63495748 |
| 28 | response to muramyl dipeptide (GO:0032495) | 2.62573055 |
| 29 | histone H3-K9 demethylation (GO:0033169) | 2.62026938 |
| 30 | locomotory exploration behavior (GO:0035641) | 2.61919016 |
| 31 | histone demethylation (GO:0016577) | 2.58801953 |
| 32 | response to interleukin-15 (GO:0070672) | 2.56991514 |
| 33 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56737232 |
| 34 | cellular response to epinephrine stimulus (GO:0071872) | 2.56058152 |
| 35 | cellular potassium ion homeostasis (GO:0030007) | 2.53975299 |
| 36 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.53753468 |
| 37 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.53615631 |
| 38 | protein K11-linked deubiquitination (GO:0035871) | 2.51514712 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 2.49047559 |
| 40 | B cell homeostasis (GO:0001782) | 2.48760488 |
| 41 | positive T cell selection (GO:0043368) | 2.48631040 |
| 42 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.46408982 |
| 43 | response to nerve growth factor (GO:1990089) | 2.46408982 |
| 44 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.46066132 |
| 45 | photoreceptor cell differentiation (GO:0046530) | 2.46002321 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 2.46002321 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.43935262 |
| 48 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.42316537 |
| 49 | phospholipid translocation (GO:0045332) | 2.41005196 |
| 50 | lipid translocation (GO:0034204) | 2.41005196 |
| 51 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.40961104 |
| 52 | modulation by symbiont of host immune response (GO:0052553) | 2.40728194 |
| 53 | positive regulation by symbiont of host defense response (GO:0052509) | 2.40728194 |
| 54 | modulation by symbiont of host defense response (GO:0052031) | 2.40728194 |
| 55 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.40728194 |
| 56 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.40728194 |
| 57 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.40728194 |
| 58 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.39929993 |
| 59 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.39381522 |
| 60 | peptidyl-threonine phosphorylation (GO:0018107) | 2.38822564 |
| 61 | negative thymic T cell selection (GO:0045060) | 2.36920973 |
| 62 | protein targeting to Golgi (GO:0000042) | 2.36667383 |
| 63 | growth hormone receptor signaling pathway (GO:0060396) | 2.36430748 |
| 64 | lymph vessel development (GO:0001945) | 2.35339583 |
| 65 | neuron recognition (GO:0008038) | 2.34437683 |
| 66 | dendritic spine morphogenesis (GO:0060997) | 2.34170102 |
| 67 | presynaptic membrane assembly (GO:0097105) | 2.33563651 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.32552218 |
| 69 | oxygen transport (GO:0015671) | 2.32447881 |
| 70 | hepatocyte apoptotic process (GO:0097284) | 2.32170926 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.31142668 |
| 72 | peptidyl-threonine modification (GO:0018210) | 2.30411993 |
| 73 | vocalization behavior (GO:0071625) | 2.30411858 |
| 74 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.28488508 |
| 75 | nucleus localization (GO:0051647) | 2.27792411 |
| 76 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.27455659 |
| 77 | negative T cell selection (GO:0043383) | 2.26934271 |
| 78 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.26607767 |
| 79 | response to laminar fluid shear stress (GO:0034616) | 2.26272169 |
| 80 | nuclear pore complex assembly (GO:0051292) | 2.25673517 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.24825070 |
| 82 | potassium ion import (GO:0010107) | 2.24803540 |
| 83 | regulation of RNA export from nucleus (GO:0046831) | 2.24364212 |
| 84 | histone H3-K4 trimethylation (GO:0080182) | 2.23291602 |
| 85 | axonal fasciculation (GO:0007413) | 2.23236471 |
| 86 | gamma-aminobutyric acid transport (GO:0015812) | 2.22512637 |
| 87 | negative regulation of cell killing (GO:0031342) | 2.22177522 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.22177522 |
| 89 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.20496121 |
| 90 | establishment of protein localization to Golgi (GO:0072600) | 2.20324446 |
| 91 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.19460919 |
| 92 | cellular response to growth hormone stimulus (GO:0071378) | 2.19232388 |
| 93 | regulation of protein polyubiquitination (GO:1902914) | 2.18936044 |
| 94 | protein dealkylation (GO:0008214) | 2.18454167 |
| 95 | protein demethylation (GO:0006482) | 2.18454167 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.18252903 |
| 97 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.17928839 |
| 98 | protein localization to endosome (GO:0036010) | 2.17337761 |
| 99 | detection of external biotic stimulus (GO:0098581) | 2.17119393 |
| 100 | positive regulation of potassium ion transport (GO:0043268) | 2.16683703 |
| 101 | axon extension (GO:0048675) | 2.16584605 |
| 102 | regulation of necroptotic process (GO:0060544) | 2.16187249 |
| 103 | neutrophil activation involved in immune response (GO:0002283) | 2.16092805 |
| 104 | chemical homeostasis within a tissue (GO:0048875) | 2.15672302 |
| 105 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.15447621 |
| 106 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.15116053 |
| 107 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.14789899 |
| 108 | positive regulation of B cell differentiation (GO:0045579) | 2.14208250 |
| 109 | tolerance induction (GO:0002507) | 2.14103026 |
| 110 | T cell migration (GO:0072678) | 2.13868969 |
| 111 | positive regulation of granulocyte differentiation (GO:0030854) | 2.13461804 |
| 112 | regulation of dendritic spine development (GO:0060998) | 2.13299427 |
| 113 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.13005866 |
| 114 | negative regulation of sodium ion transport (GO:0010766) | 2.12182691 |
| 115 | negative regulation of T cell mediated immunity (GO:0002710) | 2.12138476 |
| 116 | glial cell proliferation (GO:0014009) | 2.11989061 |
| 117 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.11691955 |
| 118 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.11260464 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.11260464 |
| 120 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.11205554 |
| 121 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.11010950 |
| 122 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.09511702 |
| 123 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.09384262 |
| 124 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.09125006 |
| 125 | positive regulation of Rap GTPase activity (GO:0032854) | 2.08959668 |
| 126 | regulation of macrophage cytokine production (GO:0010935) | 2.08888291 |
| 127 | T cell selection (GO:0045058) | 2.08469160 |
| 128 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.08451629 |
| 129 | negative regulation of catenin import into nucleus (GO:0035414) | 2.08277205 |
| 130 | response to epinephrine (GO:0071871) | 2.07822714 |
| 131 | detection of other organism (GO:0098543) | 2.07312542 |
| 132 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.07273193 |
| 133 | regulation of membrane repolarization (GO:0060306) | 2.06799884 |
| 134 | regulation of Rap GTPase activity (GO:0032317) | 2.06600595 |
| 135 | positive thymic T cell selection (GO:0045059) | 2.06191893 |
| 136 | parental behavior (GO:0060746) | 2.06144334 |
| 137 | presynaptic membrane organization (GO:0097090) | 2.05901890 |
| 138 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.05509799 |
| 139 | regulation of Rac protein signal transduction (GO:0035020) | 2.05038702 |
| 140 | myelin assembly (GO:0032288) | 2.04813235 |
| 141 | prepulse inhibition (GO:0060134) | 2.04781239 |
| 142 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.04495680 |
| 143 | establishment of endothelial barrier (GO:0061028) | 2.04264035 |
| 144 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.04232380 |
| 145 | coronary vasculature morphogenesis (GO:0060977) | 2.03863783 |
| 146 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.03848462 |
| 147 | clathrin coat assembly (GO:0048268) | 2.03483933 |
| 148 | regulation of sarcomere organization (GO:0060297) | 2.02544602 |
| 149 | neuron cell-cell adhesion (GO:0007158) | 2.02205799 |
| 150 | cerebral cortex cell migration (GO:0021795) | 2.02123960 |
| 151 | surfactant homeostasis (GO:0043129) | 2.01693360 |
| 152 | regulation of cell communication by electrical coupling (GO:0010649) | 2.01343032 |
| 153 | maternal behavior (GO:0042711) | 2.01182502 |
| 154 | relaxation of cardiac muscle (GO:0055119) | 2.00183275 |
| 155 | plasma membrane repair (GO:0001778) | 1.99689876 |
| 156 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.99652280 |
| 157 | suckling behavior (GO:0001967) | 1.97812335 |
| 158 | ganglion development (GO:0061548) | 1.97147522 |
| 159 | mating behavior (GO:0007617) | 1.96887309 |
| 160 | limb bud formation (GO:0060174) | 1.96788309 |
| 161 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.96680515 |
| 162 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 1.96357246 |
| 163 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 1.95769707 |
| 164 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.95416628 |
| 165 | phospholipid dephosphorylation (GO:0046839) | 1.95143900 |
| 166 | activation of protein kinase A activity (GO:0034199) | 1.94601901 |
| 167 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 1.94542677 |
| 168 | neuronal ion channel clustering (GO:0045161) | 1.93546645 |
| 169 | regulation of cardiac muscle hypertrophy (GO:0010611) | 1.92964708 |
| 170 | negative regulation of Rho protein signal transduction (GO:0035024) | 1.92885503 |
| 171 | cAMP catabolic process (GO:0006198) | 1.92479916 |
| 172 | import into cell (GO:0098657) | 1.91474133 |
| 173 | camera-type eye morphogenesis (GO:0048593) | 1.91464716 |
| 174 | glutamate receptor signaling pathway (GO:0007215) | 1.91252935 |
| 175 | protein localization to synapse (GO:0035418) | 1.91041153 |
| 176 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.90790572 |
| 177 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 1.90587273 |
| 178 | regulation of potassium ion transmembrane transport (GO:1901379) | 1.90460885 |
| 179 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.90157705 |
| 180 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 1.89786279 |
| 181 | regulation of muscle hypertrophy (GO:0014743) | 1.89607064 |
| 182 | L-amino acid import (GO:0043092) | 1.89127765 |
| 183 | regulation of glutamate receptor signaling pathway (GO:1900449) | 1.88889869 |
| 184 | synapse assembly (GO:0007416) | 1.88840918 |
| 185 | establishment of nucleus localization (GO:0040023) | 1.87763769 |
| 186 | neuromuscular junction development (GO:0007528) | 1.87254981 |
| 187 | vesicle transport along microtubule (GO:0047496) | 1.86810109 |
| 188 | cyclic nucleotide catabolic process (GO:0009214) | 1.86631350 |
| 189 | detection of calcium ion (GO:0005513) | 1.86607457 |
| 190 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 1.86375565 |
| 191 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.85872997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.15891245 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93543261 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.72945545 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55665716 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53901709 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.48719230 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.38985183 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.35263675 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32184468 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.27987844 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18660681 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.10197387 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03733736 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01424450 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99878483 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96108195 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95243806 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.95241213 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92814864 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.91487184 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.90068827 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.88749948 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.88579050 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88088976 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87884554 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85824474 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.84227482 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.84227482 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82187219 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78588973 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76591715 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72966405 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72848553 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70009663 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65922895 |
| 36 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65659401 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64595341 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.64510788 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63332569 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61472521 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60826965 |
| 42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.60603154 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.59221994 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59209173 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57878111 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55710530 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.54270100 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53950959 |
| 49 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53690530 |
| 50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47667218 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44496095 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43441484 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43419101 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43291402 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41910180 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41321277 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41267491 |
| 58 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40931621 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40748156 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40569055 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39939691 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39459680 |
| 63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38971001 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37590613 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35952215 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35392990 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32516962 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32226899 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29707697 |
| 70 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28783206 |
| 71 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28783206 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.28403639 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28220104 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27557238 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26258754 |
| 76 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25252111 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24237101 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23477195 |
| 79 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23032810 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22563748 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21653781 |
| 82 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.21170900 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20631315 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20475816 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20246487 |
| 86 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19408409 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19215887 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17888082 |
| 89 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.17859531 |
| 90 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.17813017 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16927524 |
| 92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16703520 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16626824 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14470439 |
| 95 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14313201 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13907080 |
| 97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13766702 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13599800 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.12881958 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12167763 |
| 101 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12096597 |
| 102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11876862 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11876862 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11138997 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10622561 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10578658 |
| 107 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10405953 |
| 108 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10018839 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09869497 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 1.09766415 |
| 111 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09752774 |
| 112 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08591690 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08167406 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08095079 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07869308 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07248152 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07248152 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07030782 |
| 119 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06737458 |
| 120 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.05189691 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05096817 |
| 122 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04979362 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04429685 |
| 124 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04256820 |
| 125 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03999364 |
| 126 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03182257 |
| 127 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.02349010 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02323941 |
| 129 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02141122 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01616937 |
| 131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01537166 |
| 132 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01427323 |
| 133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01158025 |
| 134 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00908303 |
| 135 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00558640 |
| 136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00556582 |
| 137 | MYB_26560356_Chip-Seq_TH1_Human | 1.00263574 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99541421 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98483282 |
| 140 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98010248 |
| 141 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97671378 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97608938 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97026222 |
| 144 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95800352 |
| 145 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95344272 |
| 146 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94254204 |
| 147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94215033 |
| 148 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93821202 |
| 149 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93145188 |
| 150 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92706886 |
| 151 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91195453 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90718656 |
| 153 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88830068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.74947525 |
| 2 | MP0003787_abnormal_imprinting | 3.10330326 |
| 3 | MP0008057_abnormal_DNA_replication | 2.99568583 |
| 4 | MP0003724_increased_susceptibility_to | 2.74350933 |
| 5 | MP0000013_abnormal_adipose_tissue | 2.60706156 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.46707622 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.43004399 |
| 8 | MP0003828_pulmonary_edema | 2.40804191 |
| 9 | MP0003880_abnormal_central_pattern | 2.20307848 |
| 10 | MP0004130_abnormal_muscle_cell | 2.17863578 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.16060670 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.14963638 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 2.12275644 |
| 14 | MP0001958_emphysema | 2.09858807 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.07248874 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.01358604 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 1.95978552 |
| 18 | MP0004270_analgesia | 1.93670779 |
| 19 | MP0003436_decreased_susceptibility_to | 1.90961372 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 1.88891532 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.87621168 |
| 22 | MP0005409_darkened_coat_color | 1.84182808 |
| 23 | MP0001486_abnormal_startle_reflex | 1.83374804 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.81440397 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.78854794 |
| 26 | MP0000751_myopathy | 1.77764888 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.74213340 |
| 28 | MP0001177_atelectasis | 1.72686355 |
| 29 | MP0009745_abnormal_behavioral_response | 1.70080989 |
| 30 | MP0000003_abnormal_adipose_tissue | 1.69904738 |
| 31 | MP0004484_altered_response_of | 1.69106132 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.69038834 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.67440367 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.66494080 |
| 35 | MP0003045_fibrosis | 1.66472214 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.65947082 |
| 37 | MP0000778_abnormal_nervous_system | 1.63698988 |
| 38 | MP0004134_abnormal_chest_morphology | 1.61491590 |
| 39 | MP0008260_abnormal_autophagy | 1.61065082 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.57249493 |
| 41 | MP0001851_eye_inflammation | 1.56484955 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.55708073 |
| 43 | MP0001800_abnormal_humoral_immune | 1.55468007 |
| 44 | MP0004742_abnormal_vestibular_system | 1.54139753 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.53040384 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.53020864 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.52671479 |
| 48 | MP0009046_muscle_twitch | 1.51832914 |
| 49 | MP0005248_abnormal_Harderian_gland | 1.51201682 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.48632376 |
| 51 | MP0004883_abnormal_blood_vessel | 1.48212197 |
| 52 | MP0000685_abnormal_immune_system | 1.47624522 |
| 53 | MP0003303_peritoneal_inflammation | 1.46806630 |
| 54 | * MP0001879_abnormal_lymphatic_vessel | 1.46777657 |
| 55 | MP0002009_preneoplasia | 1.45799196 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.42857116 |
| 57 | MP0002064_seizures | 1.39956845 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.38157067 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.38018426 |
| 60 | MP0005171_absent_coat_pigmentation | 1.37592786 |
| 61 | MP0001790_abnormal_immune_system | 1.36633896 |
| 62 | MP0005387_immune_system_phenotype | 1.36633896 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.35816021 |
| 64 | MP0002184_abnormal_innervation | 1.35252217 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.34653366 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.33659922 |
| 67 | MP0005164_abnormal_response_to | 1.33153043 |
| 68 | MP0002572_abnormal_emotion/affect_behav | 1.33137032 |
| 69 | MP0006054_spinal_hemorrhage | 1.33045942 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.31637019 |
| 71 | MP0002419_abnormal_innate_immunity | 1.30884338 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.29701517 |
| 73 | MP0003690_abnormal_glial_cell | 1.27732879 |
| 74 | MP0006276_abnormal_autonomic_nervous | 1.27432413 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.26039798 |
| 76 | MP0005503_abnormal_tendon_morphology | 1.25473280 |
| 77 | MP0005451_abnormal_body_composition | 1.25317912 |
| 78 | MP0008569_lethality_at_weaning | 1.23382866 |
| 79 | MP0001984_abnormal_olfaction | 1.23023456 |
| 80 | MP0005375_adipose_tissue_phenotype | 1.22802527 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.22546783 |
| 82 | MP0002723_abnormal_immune_serum | 1.22184767 |
| 83 | MP0002090_abnormal_vision | 1.21689029 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.20832957 |
| 85 | MP0004947_skin_inflammation | 1.20805427 |
| 86 | MP0000767_abnormal_smooth_muscle | 1.20539571 |
| 87 | MP0002735_abnormal_chemical_nociception | 1.19644456 |
| 88 | MP0002166_altered_tumor_susceptibility | 1.19534166 |
| 89 | MP0001819_abnormal_immune_cell | 1.19496255 |
| 90 | MP0002133_abnormal_respiratory_system | 1.19001844 |
| 91 | MP0005388_respiratory_system_phenotype | 1.19001844 |
| 92 | MP0002398_abnormal_bone_marrow | 1.17936274 |
| 93 | MP0001485_abnormal_pinna_reflex | 1.17652041 |
| 94 | MP0002405_respiratory_system_inflammati | 1.16026312 |
| 95 | MP0003279_aneurysm | 1.13247960 |
| 96 | MP0002332_abnormal_exercise_endurance | 1.12776215 |
| 97 | MP0004885_abnormal_endolymph | 1.12672115 |
| 98 | MP0000920_abnormal_myelination | 1.09098262 |
| 99 | MP0005253_abnormal_eye_physiology | 1.08963578 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 1.07667343 |
| 101 | MP0000703_abnormal_thymus_morphology | 1.07217146 |
| 102 | MP0004084_abnormal_cardiac_muscle | 1.06146177 |
| 103 | MP0002272_abnormal_nervous_system | 1.06087853 |
| 104 | MP0005275_abnormal_skin_tensile | 1.04228490 |
| 105 | MP0003868_abnormal_feces_composition | 1.03995773 |
| 106 | MP0003091_abnormal_cell_migration | 1.02556476 |
| 107 | MP0003448_altered_tumor_morphology | 1.00612731 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.99796375 |
| 109 | MP0000716_abnormal_immune_system | 0.99771155 |
| 110 | MP0005464_abnormal_platelet_physiology | 0.98834172 |
| 111 | MP0008004_abnormal_stomach_pH | 0.98595570 |
| 112 | * MP0004215_abnormal_myocardial_fiber | 0.97842334 |
| 113 | MP0001915_intracranial_hemorrhage | 0.97835416 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.97828453 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.97350596 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.96704696 |
| 117 | MP0004924_abnormal_behavior | 0.96495908 |
| 118 | MP0005386_behavior/neurological_phenoty | 0.96495908 |
| 119 | MP0004381_abnormal_hair_follicle | 0.95820202 |
| 120 | MP0001545_abnormal_hematopoietic_system | 0.94986099 |
| 121 | MP0005397_hematopoietic_system_phenotyp | 0.94986099 |
| 122 | MP0005310_abnormal_salivary_gland | 0.94624595 |
| 123 | MP0002882_abnormal_neuron_morphology | 0.94395114 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.93856207 |
| 125 | MP0003121_genomic_imprinting | 0.93664812 |
| 126 | * MP0005195_abnormal_posterior_eye | 0.92698248 |
| 127 | MP0005025_abnormal_response_to | 0.92251826 |
| 128 | * MP0005621_abnormal_cell_physiology | 0.92212627 |
| 129 | MP0004036_abnormal_muscle_relaxation | 0.91062739 |
| 130 | MP0009250_abnormal_appendicular_skeleto | 0.90416985 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.90214417 |
| 132 | MP0002557_abnormal_social/conspecific_i | 0.88853081 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.88408733 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.88001804 |
| 135 | MP0002722_abnormal_immune_system | 0.87923736 |
| 136 | MP0002896_abnormal_bone_mineralization | 0.87156707 |
| 137 | MP0002736_abnormal_nociception_after | 0.86662666 |
| 138 | MP0004085_abnormal_heartbeat | 0.85795554 |
| 139 | MP0000689_abnormal_spleen_morphology | 0.85447029 |
| 140 | MP0003385_abnormal_body_wall | 0.84612337 |
| 141 | MP0006138_congestive_heart_failure | 0.84377033 |
| 142 | MP0001853_heart_inflammation | 0.83229841 |
| 143 | MP0003633_abnormal_nervous_system | 0.83004973 |
| 144 | MP0002928_abnormal_bile_duct | 0.82679880 |
| 145 | * MP0005620_abnormal_muscle_contractility | 0.82586835 |
| 146 | MP0002837_dystrophic_cardiac_calcinosis | 0.82585586 |
| 147 | MP0006072_abnormal_retinal_apoptosis | 0.82145385 |
| 148 | MP0009785_altered_susceptibility_to | 0.81891968 |
| 149 | MP0001943_abnormal_respiration | 0.81747033 |
| 150 | MP0001502_abnormal_circadian_rhythm | 0.81262733 |
| 151 | MP0000858_altered_metastatic_potential | 0.80766988 |
| 152 | MP0004272_abnormal_basement_membrane | 0.80209454 |
| 153 | MP0002006_tumorigenesis | 0.79596357 |
| 154 | MP0001324_abnormal_eye_pigmentation | 0.79594741 |
| 155 | MP0005023_abnormal_wound_healing | 0.79547840 |
| 156 | MP0002168_other_aberrant_phenotype | 0.79482443 |
| 157 | * MP0000249_abnormal_blood_vessel | 0.79367798 |
| 158 | MP0002971_abnormal_brown_adipose | 0.79144937 |
| 159 | MP0010678_abnormal_skin_adnexa | 0.78966376 |
| 160 | MP0004510_myositis | 0.78849757 |
| 161 | MP0001188_hyperpigmentation | 0.78555713 |
| 162 | MP0002229_neurodegeneration | 0.77583065 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.77294890 |
| 164 | MP0003172_abnormal_lysosome_physiology | 0.77037221 |
| 165 | MP0010307_abnormal_tumor_latency | 0.76679604 |
| 166 | * MP0009115_abnormal_fat_cell | 0.76380385 |
| 167 | MP0000733_abnormal_muscle_development | 0.76114804 |
| 168 | MP0000015_abnormal_ear_pigmentation | 0.75720384 |
| 169 | MP0002102_abnormal_ear_morphology | 0.75078623 |
| 170 | MP0000427_abnormal_hair_cycle | 0.75008666 |
| 171 | MP0001501_abnormal_sleep_pattern | 0.73792493 |
| 172 | MP0004782_abnormal_surfactant_physiolog | 0.73646526 |
| 173 | MP0002752_abnormal_somatic_nervous | 0.73116566 |
| 174 | * MP0002972_abnormal_cardiac_muscle | 0.72307944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 3.96602328 |
| 2 | Exotropia (HP:0000577) | 3.33857396 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.26115516 |
| 4 | Asymmetry of the thorax (HP:0001555) | 3.22470617 |
| 5 | Febrile seizures (HP:0002373) | 3.19891070 |
| 6 | Focal motor seizures (HP:0011153) | 2.77330790 |
| 7 | Spontaneous hematomas (HP:0007420) | 2.75944609 |
| 8 | Macroorchidism (HP:0000053) | 2.70061611 |
| 9 | T lymphocytopenia (HP:0005403) | 2.68269939 |
| 10 | Absent frontal sinuses (HP:0002688) | 2.63055509 |
| 11 | Cone-rod dystrophy (HP:0000548) | 2.61451344 |
| 12 | Atonic seizures (HP:0010819) | 2.61277632 |
| 13 | Heterotopia (HP:0002282) | 2.58382186 |
| 14 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.57624043 |
| 15 | Excessive salivation (HP:0003781) | 2.49330051 |
| 16 | Drooling (HP:0002307) | 2.49330051 |
| 17 | Abnormality of the fingertips (HP:0001211) | 2.48305489 |
| 18 | Arterial tortuosity (HP:0005116) | 2.48271941 |
| 19 | Abnormality of T cell number (HP:0011839) | 2.45876042 |
| 20 | Focal seizures (HP:0007359) | 2.43419559 |
| 21 | Widely spaced teeth (HP:0000687) | 2.41776460 |
| 22 | Dilatation of the ascending aorta (HP:0005111) | 2.41004826 |
| 23 | Hypoplasia of the iris (HP:0007676) | 2.40856597 |
| 24 | Thyroid carcinoma (HP:0002890) | 2.40534998 |
| 25 | Central scotoma (HP:0000603) | 2.33540361 |
| 26 | Blue irides (HP:0000635) | 2.32309284 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30946559 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.30946559 |
| 29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29329770 |
| 30 | Subaortic stenosis (HP:0001682) | 2.29329770 |
| 31 | Hematochezia (HP:0002573) | 2.28659271 |
| 32 | Inappropriate behavior (HP:0000719) | 2.27744380 |
| 33 | Intellectual disability, moderate (HP:0002342) | 2.26820449 |
| 34 | Vascular tortuosity (HP:0004948) | 2.26288013 |
| 35 | Spondylolisthesis (HP:0003302) | 2.24065001 |
| 36 | Prolonged QT interval (HP:0001657) | 2.23530411 |
| 37 | Hyperthyroidism (HP:0000836) | 2.20837861 |
| 38 | Chorioretinal atrophy (HP:0000533) | 2.19413636 |
| 39 | Acute myeloid leukemia (HP:0004808) | 2.18700704 |
| 40 | Poor eye contact (HP:0000817) | 2.18390190 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.18331474 |
| 42 | Lower limb amyotrophy (HP:0007210) | 2.17747082 |
| 43 | Hypoplastic ischia (HP:0003175) | 2.15943605 |
| 44 | Broad-based gait (HP:0002136) | 2.13735763 |
| 45 | Cellulitis (HP:0100658) | 2.11099924 |
| 46 | Aortic aneurysm (HP:0004942) | 2.09558432 |
| 47 | Impaired social interactions (HP:0000735) | 2.08914456 |
| 48 | Abnormal social behavior (HP:0012433) | 2.08914456 |
| 49 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.08670974 |
| 50 | Progressive inability to walk (HP:0002505) | 2.08011188 |
| 51 | Insidious onset (HP:0003587) | 2.06289649 |
| 52 | Termporal pattern (HP:0011008) | 2.06289649 |
| 53 | Mitral valve prolapse (HP:0001634) | 2.06059599 |
| 54 | Abnormality of the ischium (HP:0003174) | 2.06009083 |
| 55 | Dislocated radial head (HP:0003083) | 2.05763849 |
| 56 | Generalized hypopigmentation of hair (HP:0011358) | 2.04729373 |
| 57 | * Subacute progressive viral hepatitis (HP:0006572) | 2.02885776 |
| 58 | Absence seizures (HP:0002121) | 2.02012460 |
| 59 | Curly hair (HP:0002212) | 2.01723806 |
| 60 | Difficulty running (HP:0009046) | 2.01700241 |
| 61 | Action tremor (HP:0002345) | 2.01469208 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.01411561 |
| 63 | Broad ribs (HP:0000885) | 2.01297048 |
| 64 | Epileptic encephalopathy (HP:0200134) | 2.00369644 |
| 65 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00005974 |
| 66 | Papilledema (HP:0001085) | 1.99904327 |
| 67 | Gingivitis (HP:0000230) | 1.99777026 |
| 68 | Abnormality of salivation (HP:0100755) | 1.98228950 |
| 69 | Buphthalmos (HP:0000557) | 1.97365951 |
| 70 | Dysmetric saccades (HP:0000641) | 1.96859704 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 1.96569696 |
| 72 | Abnormality of the nasal septum (HP:0000419) | 1.95504135 |
| 73 | Midline defect of the nose (HP:0004122) | 1.95060392 |
| 74 | Recurrent abscess formation (HP:0002722) | 1.94825887 |
| 75 | Chronic hepatic failure (HP:0100626) | 1.92183379 |
| 76 | Congenital stationary night blindness (HP:0007642) | 1.89724399 |
| 77 | Aqueductal stenosis (HP:0002410) | 1.87943071 |
| 78 | Conjunctival telangiectasia (HP:0000524) | 1.87824989 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 1.87684484 |
| 80 | Aortic dissection (HP:0002647) | 1.87035746 |
| 81 | Fair hair (HP:0002286) | 1.86904698 |
| 82 | Generalized tonic-clonic seizures (HP:0002069) | 1.86849340 |
| 83 | Spinal cord lesions (HP:0100561) | 1.86762552 |
| 84 | Syringomyelia (HP:0003396) | 1.86762552 |
| 85 | Truncal obesity (HP:0001956) | 1.86434494 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 1.86323338 |
| 87 | Truncal ataxia (HP:0002078) | 1.86229203 |
| 88 | Osteomyelitis (HP:0002754) | 1.84976216 |
| 89 | Abnormality of the radial head (HP:0003995) | 1.84713904 |
| 90 | Relative macrocephaly (HP:0004482) | 1.84574393 |
| 91 | Peritonitis (HP:0002586) | 1.84042671 |
| 92 | Mild short stature (HP:0003502) | 1.83021944 |
| 93 | * Overgrowth (HP:0001548) | 1.83002537 |
| 94 | Abnormality of the frontal sinuses (HP:0002687) | 1.82759626 |
| 95 | Hyperventilation (HP:0002883) | 1.82714815 |
| 96 | Obstructive sleep apnea (HP:0002870) | 1.81483570 |
| 97 | Aneurysm (HP:0002617) | 1.81256870 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81241869 |
| 99 | Protruding tongue (HP:0010808) | 1.81236738 |
| 100 | Slow saccadic eye movements (HP:0000514) | 1.79887965 |
| 101 | Coarse hair (HP:0002208) | 1.79770630 |
| 102 | Cerebral aneurysm (HP:0004944) | 1.79261277 |
| 103 | Decreased subcutaneous fat (HP:0001002) | 1.77678551 |
| 104 | Ankyloglossia (HP:0010296) | 1.77219670 |
| 105 | Thick nail (HP:0001805) | 1.77166133 |
| 106 | Dysdiadochokinesis (HP:0002075) | 1.75826266 |
| 107 | Gaze-evoked nystagmus (HP:0000640) | 1.74335780 |
| 108 | Recurrent bronchitis (HP:0002837) | 1.73815869 |
| 109 | Cystic hygroma (HP:0000476) | 1.73576996 |
| 110 | Protrusio acetabuli (HP:0003179) | 1.73567823 |
| 111 | Thickened calvaria (HP:0002684) | 1.72936503 |
| 112 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.72786003 |
| 113 | Hyporeflexia of lower limbs (HP:0002600) | 1.71547359 |
| 114 | Infantile muscular hypotonia (HP:0008947) | 1.71155366 |
| 115 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.70512700 |
| 116 | Persistence of primary teeth (HP:0006335) | 1.69349389 |
| 117 | Onion bulb formation (HP:0003383) | 1.69163958 |
| 118 | Deep philtrum (HP:0002002) | 1.68696072 |
| 119 | Tubulointerstitial nephritis (HP:0001970) | 1.68197243 |
| 120 | Volvulus (HP:0002580) | 1.68195174 |
| 121 | Recurrent viral infections (HP:0004429) | 1.67879629 |
| 122 | Abnormality of the calf musculature (HP:0001430) | 1.67749059 |
| 123 | * Viral hepatitis (HP:0006562) | 1.67270413 |
| 124 | Venous abnormality (HP:0002624) | 1.67124087 |
| 125 | Wormian bones (HP:0002645) | 1.66923069 |
| 126 | Abnormality of incisor morphology (HP:0011063) | 1.66766422 |
| 127 | Fatigue (HP:0012378) | 1.66522375 |
| 128 | Cortical dysplasia (HP:0002539) | 1.66480333 |
| 129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66369666 |
| 130 | Submucous cleft hard palate (HP:0000176) | 1.65728635 |
| 131 | Scotoma (HP:0000575) | 1.65009750 |
| 132 | Abnormality of the sella turcica (HP:0002679) | 1.64961479 |
| 133 | Cubitus valgus (HP:0002967) | 1.64742439 |
| 134 | Slender build (HP:0001533) | 1.64633914 |
| 135 | Disproportionate tall stature (HP:0001519) | 1.63486181 |
| 136 | Calf muscle hypertrophy (HP:0008981) | 1.63293168 |
| 137 | Broad metatarsal (HP:0001783) | 1.63278243 |
| 138 | Narrow palate (HP:0000189) | 1.63267249 |
| 139 | Venous insufficiency (HP:0005293) | 1.62530802 |
| 140 | Progressive cerebellar ataxia (HP:0002073) | 1.62335721 |
| 141 | Autoimmune hemolytic anemia (HP:0001890) | 1.61696606 |
| 142 | Macular degeneration (HP:0000608) | 1.61441436 |
| 143 | Dialeptic seizures (HP:0011146) | 1.61363795 |
| 144 | Gingival bleeding (HP:0000225) | 1.61179800 |
| 145 | Abnormality of macrophages (HP:0004311) | 1.60524777 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.60324890 |
| 147 | Decreased motor nerve conduction velocity (HP:0003431) | 1.59807761 |
| 148 | Polycythemia (HP:0001901) | 1.59616847 |
| 149 | Periodontitis (HP:0000704) | 1.59556434 |
| 150 | Chest pain (HP:0100749) | 1.59038387 |
| 151 | Scanning speech (HP:0002168) | 1.58112664 |
| 152 | Prolonged bleeding time (HP:0003010) | 1.58056404 |
| 153 | Scapular winging (HP:0003691) | 1.57925265 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.57536663 |
| 155 | Type 1 muscle fiber predominance (HP:0003803) | 1.56533080 |
| 156 | Entropion (HP:0000621) | 1.56523372 |
| 157 | Disinhibition (HP:0000734) | 1.56382410 |
| 158 | Vertebral arch anomaly (HP:0008438) | 1.56363536 |
| 159 | Hemiplegia (HP:0002301) | 1.56190460 |
| 160 | Stereotypic behavior (HP:0000733) | 1.56129346 |
| 161 | Thickened helices (HP:0000391) | 1.55997404 |
| 162 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.55976585 |
| 163 | Open mouth (HP:0000194) | 1.55363344 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.54772243 |
| 165 | Pulmonic stenosis (HP:0001642) | 1.54711960 |
| 166 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.54144575 |
| 167 | Aplasia of the phalanges of the hand (HP:0009802) | 1.54144575 |
| 168 | Aplasia involving bones of the extremities (HP:0009825) | 1.54144575 |
| 169 | Optic neuritis (HP:0100653) | 1.54086166 |
| 170 | Retrobulbar optic neuritis (HP:0100654) | 1.54086166 |
| 171 | Abnormality of oral frenula (HP:0000190) | 1.53606454 |
| 172 | Enlarged penis (HP:0000040) | 1.53137106 |
| 173 | Tibial bowing (HP:0002982) | 1.52063427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.40703404 |
| 2 | FGFR2 | 2.29563894 |
| 3 | BRD4 | 2.26511301 |
| 4 | SGK2 | 2.13091247 |
| 5 | CASK | 2.08020283 |
| 6 | CAMK1G | 1.98323368 |
| 7 | NEK9 | 1.88213204 |
| 8 | EPHA3 | 1.87009552 |
| 9 | MAP3K10 | 1.86598145 |
| 10 | NUAK1 | 1.84650414 |
| 11 | SGK3 | 1.84542901 |
| 12 | LATS1 | 1.83696737 |
| 13 | NLK | 1.83169141 |
| 14 | SGK494 | 1.82474262 |
| 15 | SGK223 | 1.82474262 |
| 16 | MAP3K4 | 1.81105208 |
| 17 | CDK12 | 1.80562524 |
| 18 | TTN | 1.77786843 |
| 19 | WNK1 | 1.76856415 |
| 20 | MAP2K3 | 1.73954831 |
| 21 | STK39 | 1.66767191 |
| 22 | FGFR3 | 1.61673168 |
| 23 | YES1 | 1.58785227 |
| 24 | MARK1 | 1.55713194 |
| 25 | AKT3 | 1.55341471 |
| 26 | STK24 | 1.54868830 |
| 27 | TNIK | 1.52986082 |
| 28 | MAP3K6 | 1.52274817 |
| 29 | DMPK | 1.43317406 |
| 30 | CAMK1D | 1.42113815 |
| 31 | NTRK3 | 1.41550515 |
| 32 | PTK6 | 1.37551742 |
| 33 | BLK | 1.32945413 |
| 34 | IRAK4 | 1.32397850 |
| 35 | TYK2 | 1.30376171 |
| 36 | ERBB3 | 1.29389586 |
| 37 | CSK | 1.28178473 |
| 38 | MAP4K1 | 1.24183623 |
| 39 | PKN1 | 1.22058637 |
| 40 | ZAP70 | 1.20679342 |
| 41 | KSR2 | 1.20558413 |
| 42 | STK3 | 1.18283480 |
| 43 | MAP3K13 | 1.17849848 |
| 44 | INSRR | 1.17248809 |
| 45 | SIK3 | 1.17228959 |
| 46 | PHKG1 | 1.16879579 |
| 47 | PHKG2 | 1.16879579 |
| 48 | JAK1 | 1.15668217 |
| 49 | EPHB1 | 1.15552811 |
| 50 | IKBKE | 1.14731106 |
| 51 | FER | 1.13622040 |
| 52 | MAP2K7 | 1.12332806 |
| 53 | EPHA4 | 1.09573783 |
| 54 | HCK | 1.07261434 |
| 55 | MST1R | 1.04909055 |
| 56 | WNK4 | 1.04351859 |
| 57 | MAP3K1 | 1.03814798 |
| 58 | PDGFRA | 1.03654721 |
| 59 | IRAK1 | 1.03083690 |
| 60 | MAP3K12 | 1.03016883 |
| 61 | FGFR4 | 1.01762275 |
| 62 | PRKCH | 1.00062688 |
| 63 | JAK3 | 0.99573861 |
| 64 | SGK1 | 0.99135132 |
| 65 | PAK6 | 0.97417065 |
| 66 | JAK2 | 0.96254490 |
| 67 | PDGFRB | 0.94615966 |
| 68 | NTRK2 | 0.91760405 |
| 69 | PAK3 | 0.91573345 |
| 70 | EEF2K | 0.91567115 |
| 71 | OXSR1 | 0.90953089 |
| 72 | MAPK7 | 0.90437720 |
| 73 | PRKCQ | 0.89429353 |
| 74 | BTK | 0.89215921 |
| 75 | LMTK2 | 0.87992280 |
| 76 | PIK3CA | 0.87053693 |
| 77 | PNCK | 0.86017451 |
| 78 | CDK6 | 0.85783248 |
| 79 | SIK2 | 0.85730193 |
| 80 | PLK2 | 0.82481765 |
| 81 | MARK3 | 0.82027314 |
| 82 | TEC | 0.81976920 |
| 83 | STK11 | 0.81657961 |
| 84 | MAP2K4 | 0.81656650 |
| 85 | FES | 0.80675131 |
| 86 | RET | 0.80239207 |
| 87 | PRKAA2 | 0.79987358 |
| 88 | SIK1 | 0.78745665 |
| 89 | MELK | 0.78279394 |
| 90 | SYK | 0.78194851 |
| 91 | CSNK1A1L | 0.78071739 |
| 92 | PRKCE | 0.77182872 |
| 93 | HIPK2 | 0.77124311 |
| 94 | MAPK13 | 0.77122000 |
| 95 | RIPK1 | 0.75546261 |
| 96 | MAP3K3 | 0.74061825 |
| 97 | CDK9 | 0.73335147 |
| 98 | STK38L | 0.72552983 |
| 99 | OBSCN | 0.72486186 |
| 100 | TRPM7 | 0.71735758 |
| 101 | CDK5 | 0.70802306 |
| 102 | TNK2 | 0.70786311 |
| 103 | RAF1 | 0.70626415 |
| 104 | TRIB3 | 0.70532996 |
| 105 | IRAK2 | 0.70356085 |
| 106 | GRK1 | 0.67121419 |
| 107 | NEK6 | 0.67072100 |
| 108 | PRKD1 | 0.65543472 |
| 109 | CHUK | 0.64986537 |
| 110 | CAMKK1 | 0.64624732 |
| 111 | MAP3K2 | 0.64470984 |
| 112 | PRKAA1 | 0.64214052 |
| 113 | CAMKK2 | 0.63536271 |
| 114 | GSK3A | 0.63514412 |
| 115 | RIPK4 | 0.62388904 |
| 116 | TGFBR2 | 0.61808790 |
| 117 | MARK2 | 0.61412821 |
| 118 | MAP3K5 | 0.61336212 |
| 119 | CSNK1G2 | 0.60810247 |
| 120 | STK38 | 0.60797236 |
| 121 | MAP3K14 | 0.60350219 |
| 122 | DYRK1A | 0.59559593 |
| 123 | TXK | 0.58866275 |
| 124 | MAP3K7 | 0.58162893 |
| 125 | ROCK1 | 0.57227691 |
| 126 | LCK | 0.56895569 |
| 127 | CSNK1G1 | 0.56460649 |
| 128 | PDPK1 | 0.54607970 |
| 129 | DAPK2 | 0.53945337 |
| 130 | KSR1 | 0.53140211 |
| 131 | PBK | 0.53136038 |
| 132 | BMPR2 | 0.52572028 |
| 133 | MAPK12 | 0.52349588 |
| 134 | FYN | 0.51859584 |
| 135 | PRPF4B | 0.51805573 |
| 136 | ITK | 0.51462767 |
| 137 | ROCK2 | 0.50768738 |
| 138 | PDK1 | 0.50476422 |
| 139 | LYN | 0.50396407 |
| 140 | CAMK4 | 0.49991959 |
| 141 | PIK3CG | 0.49232155 |
| 142 | MAPK10 | 0.49099335 |
| 143 | CLK1 | 0.49034383 |
| 144 | CAMK2A | 0.49007119 |
| 145 | TAOK3 | 0.48603014 |
| 146 | RPS6KA2 | 0.48026620 |
| 147 | SCYL2 | 0.45096779 |
| 148 | MTOR | 0.44279147 |
| 149 | MAPK4 | 0.42273365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 1.87096367 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 1.68343400 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 1.64697948 |
| 4 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60600842 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 1.57817224 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.51814343 |
| 7 | Renin secretion_Homo sapiens_hsa04924 | 1.50132917 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48015082 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47669947 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.46033430 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44855417 |
| 12 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44122761 |
| 13 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.37348206 |
| 14 | Axon guidance_Homo sapiens_hsa04360 | 1.36659245 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34093605 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31208485 |
| 17 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30146078 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.30120835 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29748699 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.29093660 |
| 21 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.27492697 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.27252503 |
| 23 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26482682 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.26276352 |
| 25 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.25968362 |
| 26 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.25624577 |
| 27 | * Measles_Homo sapiens_hsa05162 | 1.22096338 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22089857 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22036312 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22001236 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20904132 |
| 32 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20567363 |
| 33 | * Hepatitis B_Homo sapiens_hsa05161 | 1.19780128 |
| 34 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.19579151 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18598672 |
| 36 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16265523 |
| 37 | * Glioma_Homo sapiens_hsa05214 | 1.16225217 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.16127582 |
| 39 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.15144870 |
| 40 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.14115650 |
| 41 | * Colorectal cancer_Homo sapiens_hsa05210 | 1.13605090 |
| 42 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13203659 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.12810346 |
| 44 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09728216 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.09578357 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.09091465 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08430730 |
| 48 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08305952 |
| 49 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07666691 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.07490949 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.06183283 |
| 52 | * Focal adhesion_Homo sapiens_hsa04510 | 1.05415066 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05152416 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.04249801 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04104560 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03921991 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03249981 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 1.03069913 |
| 59 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02287289 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00891188 |
| 61 | * Influenza A_Homo sapiens_hsa05164 | 1.00410058 |
| 62 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00300471 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99613853 |
| 64 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.99012436 |
| 65 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97297644 |
| 66 | * Hepatitis C_Homo sapiens_hsa05160 | 0.96940971 |
| 67 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95419132 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95094832 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91991418 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91825641 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91020288 |
| 72 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90635967 |
| 73 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90416044 |
| 74 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88005293 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.87868321 |
| 76 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86785307 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.86416543 |
| 78 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84944438 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84645315 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83138808 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82595770 |
| 82 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81746377 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81413008 |
| 84 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80843307 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78420941 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77821231 |
| 87 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.77088959 |
| 88 | * Prostate cancer_Homo sapiens_hsa05215 | 0.76162071 |
| 89 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.75573154 |
| 90 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74926612 |
| 91 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74078443 |
| 92 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73680458 |
| 93 | * Melanoma_Homo sapiens_hsa05218 | 0.73369208 |
| 94 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73303948 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73144155 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.72822312 |
| 97 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72378089 |
| 98 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71007712 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.70627502 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70383391 |
| 101 | * Apoptosis_Homo sapiens_hsa04210 | 0.70061185 |
| 102 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69480166 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69138186 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69112157 |
| 105 | * Platelet activation_Homo sapiens_hsa04611 | 0.69086532 |
| 106 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68729884 |
| 107 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68665455 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68469941 |
| 109 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68409568 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67549722 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66994993 |
| 112 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66826769 |
| 113 | * Amoebiasis_Homo sapiens_hsa05146 | 0.66496178 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65756706 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.65373572 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.64858339 |
| 117 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64472400 |
| 118 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64342980 |
| 119 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.62872564 |
| 120 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.62202662 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61979195 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61662312 |
| 123 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61139156 |
| 124 | * Insulin resistance_Homo sapiens_hsa04931 | 0.60906479 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.60143309 |
| 126 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.59953854 |
| 127 | Allograft rejection_Homo sapiens_hsa05330 | 0.59754121 |
| 128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59563849 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58735801 |
| 130 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56740182 |
| 131 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56479343 |
| 132 | Legionellosis_Homo sapiens_hsa05134 | 0.56005083 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.55547588 |
| 134 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55255125 |
| 135 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54998188 |
| 136 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54955141 |
| 137 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53441801 |
| 138 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52359748 |
| 139 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51915190 |
| 140 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51437672 |
| 141 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.51378381 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50393355 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50212489 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50015582 |
| 145 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49788708 |

